» Authors » Cecilie Delphin Amdal

Cecilie Delphin Amdal

Explore the profile of Cecilie Delphin Amdal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 191
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomassen D, Roychoudhury S, Amdal C, Reynders D, Musoro J, Sauerbrei W, et al.
BMC Med Res Methodol . 2025 Mar; 25(1):56. PMID: 40025441
Introduction: As patient-reported outcomes (PROs) are increasingly used in the evaluation of medical treatments, it is important that PROs are carefully analyzed and interpreted. This may be challenging due to...
2.
Thomassen D, Roychoudhury S, Amdal C, Reynders D, Musoro J, Sauerbrei W, et al.
BMC Med Res Methodol . 2024 Nov; 24(1):290. PMID: 39580440
Background: Patient-reported outcomes (PROs) play an increasing role in the evaluation of oncology treatments. At the same time, single-arm trials are commonly included in regulatory approval submissions. Because of the...
3.
Huynh T, Falk R, Hellebust T, Dale E, Astrup G, Hjermstad M, et al.
Radiother Oncol . 2024 Mar; 195:110231. PMID: 38518958
Background: There is lack of evidence on chronic fatigue (CF) following radiotherapy (RT) in survivors of head and neck cancer (HNC). We aimed to compare CF in HNC survivors > ...
4.
Huynh T, Dale E, Falk R, Hellebust T, Astrup G, Malinen E, et al.
Radiother Oncol . 2023 Dec; 190:110044. PMID: 38061420
Background: Although dysphagia is a common side effect after radiotherapy (RT) of head and neck cancer (HNC), data on long-term dysphagia is scarce. We aimed to 1) compare radiation dose...
5.
Amdal C, Moan J, Dale E, Falk R, Johansen S, Bjordal K
Clin Transl Radiat Oncol . 2023 Jul; 42:100654. PMID: 37415638
Purpose: Describe the clinical outcome of hyperfractionated re-irradiation (HFRT) in patients with recurrent or second primary (SP) head and neck cancer (HNC). Methods: This prospective observational study included HNC patients...
6.
Pe M, Alanya A, Falk R, Amdal C, Bjordal K, Chang J, et al.
Lancet Oncol . 2023 Jun; 24(6):e270-e283. PMID: 37269858
Patient-reported outcomes (PROs), such as symptoms, functioning, and other health-related quality-of-life concepts are gaining a more prominent role in the benefit-risk assessment of cancer therapies. However, varying ways of analysing,...
7.
Liu L, Choi J, Musoro J, Sauerbrei W, Amdal C, Alanya A, et al.
Lancet Oncol . 2023 May; 24(5):e197-e206. PMID: 37142381
Patient-reported outcomes (PROs) are increasingly used in single-arm cancer studies. We reviewed 60 papers published between 2018 and 2021 of single-arm studies of cancer treatment with PRO data for current...
8.
Troseid M, Arribas J, Assoumou L, Holten A, Poissy J, Terzic V, et al.
Crit Care . 2023 Jan; 27(1):9. PMID: 36627655
Background: Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. Methods: Bari-SolidAct is a phase-3, multicentre, randomised,...
9.
Amdal C, Falk R, Singer S, Pe M, Piccinin C, Bottomley A, et al.
Qual Life Res . 2022 Oct; 32(2):447-459. PMID: 36273365
Purpose: To develop and validate a health-related quality of life (HRQoL) questionnaire for patients with current or previous coronavirus disease (COVID-19) in an international setting. Methods: This multicenter international methodology...
10.
Hynne H, Aqrawi L, Jensen J, Thiede B, Palm O, Amdal C, et al.
Int J Mol Sci . 2022 Apr; 23(7). PMID: 35409074
Patients with head and neck cancer (HNC) and patients with primary Sjögren's syndrome (pSS) may exhibit similar symptoms of dry mouth and dry eyes, as a result of radiotherapy (RT)...